Company: MDXG
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001376339-25-000009
Chunk: 125

Company: MIMEDX GROUP, INC.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 15
Chunk 125
---
6 Equity and Cash Incentive Plan (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q filed on April 30, 2024).

91

ExhibitNumber  Description 10.43Form of Nonqualified Stock Option Agreement under the MiMedx Group, Inc. 2016 Equity and Cash Incentive Plan (incorporated by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q filed on April 30, 2024).10.44Credit Agreement, dated January 19, 2024 among MIMEDX GROUP, INC., a Florida corporation, as the Borrower, MIMEDX TISSUE SERVICES LLC, as a Guarantor, MIMEDX PROCESSING SERVICES, LLC, as a Guarantor, MIMEDX SUPPLY LLC, as a Guarantor, BANK OF AMERICA, NATIONAL ASSOCIATION, as a Lender and CITIZENS BANK, N.A., as Administrative Agent, the L/C Issuer, the Swingline Lender, and as a Lender (incorporated by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q filed on April 30, 2024).10.45#*Offer Letter dated June 24, 2024 from MiMedx Group, Inc. to Kim Moller10.46#Restated Key Employee Retention and Restrictive Covenant Agreement dated June 7, 2023, between the Company and Kimberly Moller.19.1#Insider Trading Policy dated January 6, 2025.21.1#Subsidiaries of MiMedx Group, Inc.23.1#Consent of Deloitte & Touche LLP, Independent Registered Public Accounting Firm.24.1#Power of Attorney (included on the signature page to this Report).31.1#Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 200231.2#Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 200232.1#Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 200232.2#Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 200297.1MiMedx